HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of peroxisome proliferator-activated receptor gamma activity suppresses pancreatic cancer cell motility.

Abstract
Peroxisome proliferator-activated receptor gamma (PPARgamma) is a ligand-activated transcription factor that has been implicated in the carcinogenesis and progression of various solid tumors, including pancreatic carcinomas. We aimed to clarify the role of this receptor in pancreatic cell motility in vitro and in metastasis in vivo. Cell motility was examined by assaying transwell migration and wound filling in Capan-1 and Panc-1 pancreatic cancer cells, with or without the PPARgamma-specific inhibitor T0070907. A severe combined immunodeficiency xenograft metastasis model was used to examine the in vivo effect of PPARgamma inhibition on pancreatic cancer metastasis. In both transwell-migration and wound-filling assays, inhibition of PPARgamma activity suppressed pancreatic cell motility without affecting in vitro cell proliferation. Inhibition of PPARgamma also suppressed liver metastasis in vivo in metastatic mice. In PPARgamma-inhibited cells, p120 catenin accumulation was induced predominantly in cell membranes, and the Ras-homologous GTPases Rac1 and Cdc42 were inactive. Inhibition of PPARgamma in pancreatic cancer cells decreased cell motility by altering p120ctn localization and by suppressing the activity of the Ras-homologous GTPases Rac1 and Cdc42. Based on these findings, PPARgamma could function as a novel target for the therapeutic control of cancer cell invasion or metastasis.
AuthorsAtsushi Nakajima, Ayako Tomimoto, Koji Fujita, Michiko Sugiyama, Hirokazu Takahashi, Ikuko Ikeda, Kunihiro Hosono, Hiroki Endo, Kyoko Yoneda, Hiroshi Iida, Masahiko Inamori, Kensuke Kubota, Satoru Saito, Noriko Nakajima, Koichiro Wada, Yoji Nagashima, Hitoshi Nakagama
JournalCancer science (Cancer Sci) Vol. 99 Issue 10 Pg. 1892-900 (Oct 2008) ISSN: 1349-7006 [Electronic] England
PMID19016747 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzamides
  • Catenins
  • Cell Adhesion Molecules
  • Ligands
  • PPAR gamma
  • Phosphoproteins
  • Pyridines
  • RNA, Small Interfering
  • T 0070907
  • Thiazolidinediones
  • Rosiglitazone
  • cdc42 GTP-Binding Protein
  • rac1 GTP-Binding Protein
  • Delta Catenin
Topics
  • Animals
  • Benzamides (pharmacology)
  • Catenins
  • Cell Adhesion Molecules (biosynthesis)
  • Cell Line, Tumor
  • Cell Movement (drug effects, genetics)
  • Humans
  • Ligands
  • Mice
  • Mice, SCID
  • Neoplasm Metastasis
  • PPAR gamma (antagonists & inhibitors)
  • Pancreatic Neoplasms (drug therapy, metabolism, pathology)
  • Phosphoproteins (biosynthesis)
  • Pyridines (pharmacology)
  • RNA, Small Interfering (metabolism)
  • Rosiglitazone
  • Thiazolidinediones (pharmacology)
  • Xenograft Model Antitumor Assays
  • cdc42 GTP-Binding Protein (metabolism)
  • rac1 GTP-Binding Protein (metabolism)
  • Delta Catenin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: